Dr Reddy’s Q3 net profit falls 38% to Rs 303 crore

  • News
  • January 27, 2018

Dr Reddy’s Laboratories today posted a 38.51 per cent decline in consolidated net profit at Rs 302.7 crore for the third quarter ended December 31.

The company had posted a net profit of Rs 492.3 crore during the same period of previous fiscal.

Its total revenue from operations stood at Rs 3,834.1 crore for the quarter under review. It was Rs 3,723.2 crore during the third quarter of 2016-17, Dr Reddy’s Labs said in a regulatory filing.

The company said total revenue from operations for the quarter was not comparable consequent to introduction of Goods and Services Tax on July 1.

“Revenue from operations for the earlier periods (before July 1) included excise duty which is now subsumed in GST,” it added.

Shares of Dr Reddy’s Labs were trading at Rs 2,490 apiece on BSE, down 2.80 per cent from previous close.

  • Related Posts

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

    Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Kota Maternal Deaths: Jaipur Expert Team Finds Sterilization and Fumigation Lapses; FDA Collects Samples, Collector Orders Action

    Kota Maternal Deaths: Jaipur Expert Team Finds Sterilization and Fumigation Lapses; FDA Collects Samples, Collector Orders Action

    Prescription Drug Diversion Crisis Deepens Across India: Massive Seizures of Pregabalin, Tramadol, Codeine Syrup and Psychotropic Capsules Expose Regulatory Failure

    Prescription Drug Diversion Crisis Deepens Across India: Massive Seizures of Pregabalin, Tramadol, Codeine Syrup and Psychotropic Capsules Expose Regulatory Failure

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Six Women Develop Serious Complications After C-Section

    Six Women Develop Serious Complications After C-Section

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected